The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies

Resource type
Journal Article
Authors/contributors
Title
The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies
Abstract
The detection of letermovir and maribavir resistance mutations highlights an ongoing clinical challenge in the management of CMV.
Publication
Current Opinion in Infectious Diseases
Date
12/2024
Volume
37
Issue
6
Pages
536-546
Accessed
12/22/24, 6:10 PM
ISSN
0951-7375, 1473-6527
Short Title
The emergence of letermovir and maribavir drug-resistant mutations
Language
en
Library Catalog
DOI.org (Crossref)
Citation
Zhu, V. Z., Horton, M. B., Haeusler, G. M., & Yong, M. K. (2024). The emergence of letermovir and maribavir drug-resistant mutations: from clinical trials to real-world studies. Current Opinion in Infectious Diseases, 37(6), 536–546. https://doi.org/10.1097/QCO.0000000000001065
Link to this record